Drug Profile
Paclitaxel ceribate
Alternative Names: BP-179; ProtaxelLatest Information Update: 05 Sep 2007
Price :
$50
*
At a glance
- Originator Interpharma Praha
- Class Antineoplastics; Paclitaxels
- Mechanism of Action Tubulin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 24 Apr 2007 Discontinued - Phase-I for Cancer in Czech Republic (unspecified route)
- 11 Jul 2003 Phase-I clinical trials in Cancer in Czech Republic (unspecified route)